通过分子动力学和马尔科夫状态建模分析,在μ-阿片类受体上绘制米特拉金因的部分激动性
Mohammad Nazri Abdul Bahari1, Liyana Azmi2, Low Chen Fei3
1Collaborative Microelectronic Design Excellence Center (CEDEC), Universiti Sains Malaysia, No. 10, Persiaran Bukit Jambul, 11900, Bayan Lepas, Pulau Pinang, Malaysia.
Scientific reports
|March 7, 2026
概括
米特拉吉宁,一个Kratom类化合物,显示部分μ-阿片类受体 (μOR) 激动因不同的形状动态. 分子模拟显示它稳定了中间状态,与吗啡不同,解释了其独特的信号配置.
科学领域:
- 药理学和分子生物物理学
- 计算化学和分子动力学
背景情况:
- 米特拉吉宁是Mitragyna speciosa (kratom) 中的一个关键类化合物,是μ-阿片类受体 (μOR) 的部分激素.
- 对于米特拉金因的亚最大疗效和μOR偏差信号的结构和动态基础仍然不太清楚.
研究的目的:
- 阐明了米特拉金因的部分激应和G蛋白偏差信号在μOR的基础上的分子机制.
- 使用先进的计算方法,比较与米特拉基尼与吗啡结合的μOR的结构动力学和动力学.
主要方法:
- 在显式脂质双层中微秒级全原子分子动力学 (MD) 模拟.
- 马尔科夫状态建模 (MSM) 来分析构造性景观和动力学.
- 分子力学/Poisson-Boltzmann表面积 (MMPBSA) 计算用于具有约束力的自由能量估计.
主要成果:
- MMPBSA的计算显示了米特拉金因和吗啡的良好结合,而米特拉金因的结合自由能量更为负面.
- MSM 显示出明显的 μOR 形态组合:吗啡稳定了类似活性状态,而米特拉基宁扩大了中间状态的采样.
- 动力学分析表明,与吗啡的纳秒级过渡相比,米特拉基宁的微秒级过渡到开放状态的时间要长得多.
结论:
- 米特拉基宁的部分激动性和偏向信号源于其稳定中间μOR构造的能力,从而减少完全活跃状态的数量.
- 这项研究为米特拉基宁在μOR的独特药理学特征提供了机制性的解释.
- 这些发现为设计具有量身定制的信号特性的新型偏向μOR配体提供了定量框架.
相关概念视频
Opioid Receptors: Overview
5.7K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
5.7K
Analgesia and Pain Management
2.5K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
2.5K
Drug-Receptor Interaction: Agonist
4.4K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
4.4K
Opioid Analgesics: Synthetic and Semisynthetic Opioids
1.3K
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.3K
Opioid Analgesics: Morphine and Other Natural Cogeners
1.3K
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
1.3K
The Two-State Receptor Model
3.4K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
3.4K


